Gene therapy and uterine leiomyomas

Clinical Obstetrics and Gynecology

Volumn 44, Issue 2, 2001, Pages 425-435

  Christman, Gregory M ^a   McCarthy, Jenifer D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; GENE PRODUCT; GONADORELIN AGONIST; GUANOSINE DERIVATIVE; PLASMID DNA; PLASMID VECTOR; PROTEIN HSV TK; RECOMBINANT DNA; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS VECTOR;

CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE FERTILITY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GENOME; HORMONAL THERAPY; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; MYOMECTOMY; NONHUMAN; REVIEW; TREATMENT INDICATION; TUMOR GROWTH; UTERUS MYOMA;

DNA, RECOMBINANT; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LEIOMYOMA; UTERINE NEOPLASMS;

EID: 0035039463     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200106000-00027     Document Type: Review

References (35)

1. Uterine leiomyomata: Etiology, symptomology, and management
2. The future of fibroid therapy
3. Rodent model of reproductive tract leiomyomata; establishment and characterization of tumor derived cell lines
4. Gene transfer technologies for the gene therapy of cancer
5. Principles of gene therapy for obstetrics and gynecology
6. The human genome project: Implications for the practicing obstetrician
7. Rival genome sequencers celebrate a milestone together
8. Molecular lysis of synovial lining cells by in vitro herpes simplex virus-thymidine kinase gene transfer
9. Prenatal applications of somatic gene therapy
10. Gene therapy for solid tumors
11. Transfer of genes to humans: Early lessons and obstacles to success
12. Targeting of retroviral vectors for gene therapy
13. The basic science of gene therapy
14. Adenovirus and adeno-associated virus as vectors for gene therapy
15. Mapping and direct visualization of a region specific viral DNA integration site on chromosome 19q13-qter
16. Herpes simplex virus for gene delivery to neurons
17. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1
18. Nonviral gene therapy; the promise of genes as pharmaceutical products
19. Cancer vaccines
20. Interleukin 2 gene therapy of residual disease in mice carrying tumors induced by HPV 16
21. Bystander effects of different enzyme-pro-drug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes
22. The "bystander effect": Tumor regression when a fraction of tumor mass is genetically modified
23. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
24. Nonviral vector-mediated thymidine kinase gene transfer and ganciclover treatment in leiomyoma cells
25. Effect of herpes simplex virus thymidine kinase expression levels on ganciclover-mediated cytotoxicity and the "bystander effect"
26. In vitro gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
27. Gene therapy for brain tumors: Regression of experimental gliomas by adeno-virus-mediated gene transfer in vivo
28. Gene therapy for peritonral dissemination of pancreatis cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene
29. Gene therapy for vascular smooth muscle cell proliferation after arterial injury
30. Efficiency of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: Long-term follow-up